SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001387131-14-002915
Filing Date
2014-08-13
Accepted
2014-08-13 16:15:25
Documents
4
Period of Report
2014-05-30
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ohr-8ka_053014.htm 8-K/A 16876
2 AUDITED CONSOLIDATED FINANCIAL STATEMENTS ex99-1.htm EX-99.1 142111
3 UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS ex99-2.htm EX-99.2 71130
4 UNAUDITED PRO FORMA CONSOLIDATED CONDENSED FINANCIAL STATEMENTS ex99-3.htm EX-99.3 110942
  Complete submission text file 0001387131-14-002915.txt   342291
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | Fiscal Year End: 0930
Type: 8-K/A | Act: 34 | File No.: 001-35963 | Film No.: 141037690
SIC: 2834 Pharmaceutical Preparations